Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

This study has been terminated.
(Regulatory decision not to proceed)
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00156962
First received: September 8, 2005
Last updated: July 17, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)